G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (buerger's disease) and their removal by immunoadsorption;Agonistische autoantikörper, die gegen G-protein gekoppelte rezeptoren (GPCR) gerichtet sind, bei patienten mit th rombangiitis obliterans und ihre entfernung durch immunadsorption

Vasa - European Journal of Vascular Medicine

Volumn 43, Issue 5, 2014, Pages 347-352

  Klein Weigel, Peter F ^a   Bimmler, Marion ^b   Hempel, Petra ^b   Schöpp, Sebastian ^a   Dreusicke, Siegrid ^a   Valerius, Jana ^a   Bohlen, Anne ^a   Boehnlein, Joana M ^a   Bestler, Daniel ^a   Funk, Stephanie ^a   Elitok, Saban ^a  

^a HELIOS KLINIKUM BERLIN BUCH   (Germany)

^b ERDE AAK Diagnostik GmbH   (Germany)

Author keywords

Autoantibodies; Buerger's disease; g protein coupled receptor; Immunoadsorption; Thromboangiitis obliterans

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; AUTOANTIBODY; ENDOTHELIN A RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; PROTEINASE ACTIVATED RECEPTOR; STREPTAVIDIN;

ACROCYANOSIS; ADULT; AMPUTATION; ANTIGEN BINDING; ARTICLE; BUERGER DISEASE; CLINICAL ARTICLE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOADSORPTION; MALE; MIDDLE AGED; PATHOGENESIS; RECURRENT DISEASE; SMOKING; VISUAL ANALOG SCALE; YOUNG ADULT;

AUTOANTIBODIES; BUERGERS DISEASE; G-PROTEIN COUPLED RECEPTOR; IMMUNOADSORPTION; THROMBOANGIITIS OBLITERANS;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, G-PROTEIN-COUPLED; SORPTION DETOXIFICATION; THROMBOANGIITIS OBLITERANS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907362373     PISSN: 03011526     EISSN: 16642872     Source Type: Journal    
DOI: 10.1024/0301-1526/a000372     Document Type: Article

References (44)

1. Buerger L. Landmark publication from the American Journal of the Medical Sciences, "Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene". 1908. Am J Med Sci 2009; 337: 274-284.
2. Dargon PT, Landry GJ. Buerger's disease. Ann Vasc Surg 2012; 26: 871-803.
3. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000; 343: 864-869.
4. Piazza G, Creager MA. Thrombangiitis obliterans. Circulation 2010; 121: 1858-1861.
5. Gulati SM, Agarwal V, Sharma V, Saha K. C3 complement components & their breakdown product (C3d) in patients of thromboangiitis obliterans. Indian J Med Res 1986; 84: 607-611.
6. Halacheva K, Gulubova MV, Manolova I, Petkov D. Expression of ICAM-1, VCAM-1, E-selectin and TNF-alpha on the endothelium of femoral and iliac arteries in thromboangiitis obliterans. Acta Histochem 2002; 104: 177-84.
7. Ketha SS, Cooper LT. The role of autoimmunity in thromboangiitis obliterans (Buerger's disease). Ann N Y Acad Sci 2013; 1285: 15-25.
8. Kim EJ, Cho BS, Lee TS, Kim SJ, Seo JW. Morphologic change of the internal elastic lamina in Buerger's disease. J Korean Med Sci 2000; 15: 44-48.
9. Kobayashi M, Ito M, Nakagawa A, Nishikimi N, Nimura Y. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 1999; 29: 451-458.
10. Lee T, Seo JW, Sumpio BE, Kim SJ. Immunobiologic analysis of arterial tissue in Buerger's disease. Eur J Vasc Endovasc Surg 2003; 25: 451-457.
11. Smolen JS, Youngchaiyud U, Weidinger P, Kojer M, Endler AT, Mayr WR, Menzel EJ. Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease). Clin Immunol Immunopathol 1978; 11: 168-177.
12. De Godoy JM, Braile DM, Godoy MF. Buerger's disease and anticardiolipin antibodies: a worse prognosis? Clin Appl Thromb Hemost 2002; 8: 85-86.
13. Eichhorn J, Sima D, Lindschau C, Turowski A, Schmidt H, Schneider W, Haller H, Luft FC. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998; 315: 17-23.
14. Gulati SM, Madhra K, Thusoo TK, Nair SK, Saha K. Autoantibodies in thromboangiitis obliterans (Buerger's disease). Angiology 1982; 33: 642-651.
15. Halacheva KS, Manolova IM, Petkov DP, Andreev AP. Study of antineutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease). Scand J Immunol 1998; 48: 544-550.
16. Dragun D, Philippe A, Catar R, Hegner B. Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies. Thromb Haemost 2009; 101: 643-648.
17. Luft FC. Activating autoantibodies and cardiovascular disease.Physiology (Bethesda) 2013; 28: 254-261.
18. Walther T, Stepan H.Agonistic antibodies against angiotensin AT1 receptor in renal and hypertensive disorders. Curr Hypertens Rep 2007; 9: 128-132.
19. Xia Y, Kellems RE. Receptor activating autoantibodies and disease: preeclampsia and beyond. Expert Rev Clin Immunol 2011; 7: 659-674.
20. Dandel M, Wallukat G, Englert A, Hetzer R. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension. Atheroscler 2013; 14 (Suppl): 203-211.
21. Fu ML, Herlitz H, Wallukat G, Hilme E, Herdner T, et al. Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet 1994; 344: 1660-1663.
22. Hempel P, Karczewski P, Kohnert K-D, Raabe J, Lemke B, Kunze R, Bimmler M (2009) Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors. Scand J Immunol 2009; 70: 159-16.
23. Karczewski P, Hempel P, Kunze R, Bimmler M. Agonistic autoantibodies to the a1-adrenergic receptor and the b2-adrenergic receptor in Alzheimer's and vascular dementia. Scand J Immunol 2012; 75: 524-530.
24. Luther HP, Homuth V, Wallukat G. Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 1997; 29: 678-682.
25. Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V, Herse F, Hubner N, Schulz H, Janczikowski M, Lindschau C, Schroeder C, Verlohren S, Morano I, Muller DN, Luft FC, Dietz R, Dechend R, Karczewski P. Potential functional relevance of a1-adrenergic receptor autoantibodies in refractory hypertension. PLoS ONE 2008; 3: e3742.
26. Zhang L, Cui L, Miao GB, Zhao WS, Wang SY, Liu XL. [Study of autoantibodies against the G-protein-coupled beta 2- and alpha 1-adrenergic and AT1 receptors in patients with primary hypertension]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002; 24: 367-369.
27. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against betaadrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989; 64: 97-103.
28. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89: 2760-2767.
29. Wallukat G, Wollenberger A. Effects of gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biochim Biophys Acta 1987; 46: 634-639.
30. Dragun D, Müller D, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer H-H, Luft FC, Wallukat G. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-569.
31. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103: 945-952.
32. Karczewski P, Haase H, Hempel P, Bimmler M. Agonistic antibody to the a1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein. Mol Cell Biochem 2010; 333: 233-242.
33. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004; 113: 1419-1429.
34. Müller J, Wallukat G, Dandel M, Bieda H, Brandes K, et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-391.
35. Zhou Z, Liao Y, Li L, Wei F, Wang B, et al. Vascular damages in rats immunized by alpha1-adrenoceptor peptides. Cell Mol Immunol 2008; 5: 349-56.
36. Zhou Z, Liao Y-H, Wei Y, Wei F, Wang B, et al. Cardiac remodeling aft er long-term stimulation by antibodies against the a1-adrenergic receptor in rats. Clin Immunol 2005; 114: 164-173.
37. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buer ger's disease). Circulation 1990; 825 (Suppl): IV3-8.
38. Shinoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol 1988; 66 Suppl 1: S243-245.
39. Baumann G, Stangl V, Klein-Weigel P, Stangl K, Laule M, Enke-Melzer K. Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study. Clin Res Cardiol 2011; 100: 683-690.
40. Klein-Weigel P, Köning C, Härtwig A, Krüger K, Gutsche-Petrak B, Dreusicke S, Thieme U, Enke-Melzer K, Urbach B, Kron J. [Immunoadsorption in thrombangiitis obliterans: a promising therapeutic option: results of a consecutive patient cohort treated in clinical routine care]. Zentralbl Chir 2012; 137: 460-465.
41. Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT, Cheng LX. Autoantibodies against AT1-receptors and alpha1 adreneric receptor in patients with hypertension. Hypertens Res 2002; 25: 641-646.
42. Staudt A, Böhm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106: 2448-2453.
43. Dragun D. The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection. Pediatr Nephrol 2007; 22: 911-914.
44. Riemekasten G, Philippe A, Näther M, Slowinski T, Müller DN, Heidecke H, Matucci-Cerinic M, Czirják L, Lukitsch I, Becker M, Kill A, van Laar JM, Catar R, Luft FC, Burmester GR, Hegner B, Dragun D. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 2011; 70: 530-536.